Lea Lowenfeld

504 total citations
19 papers, 362 citations indexed

About

Lea Lowenfeld is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Lea Lowenfeld has authored 19 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Gastroenterology. Recurrent topics in Lea Lowenfeld's work include Gastric Cancer Management and Outcomes (8 papers), Gastrointestinal Tumor Research and Treatment (7 papers) and Immunotherapy and Immune Responses (6 papers). Lea Lowenfeld is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Gastrointestinal Tumor Research and Treatment (7 papers) and Immunotherapy and Immune Responses (6 papers). Lea Lowenfeld collaborates with scholars based in United States and Japan. Lea Lowenfeld's co-authors include Brian J. Czerniecki, Shuwen Xu, Robert E. Roses, Paul J. Zhang, Carla S. Fisher, Jashodeep Datta, Elizabeth Fitzpatrick, Angela DeMichele, Jashodeep Datta and Rosemarie Mick and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Lea Lowenfeld

17 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lea Lowenfeld United States 9 251 214 72 55 51 19 362
Matilde Monti Italy 10 212 0.8× 136 0.6× 69 1.0× 48 0.9× 22 0.4× 13 365
Thomas Broughton United Kingdom 10 222 0.9× 218 1.0× 69 1.0× 60 1.1× 10 0.2× 11 406
Claudia Röefzaad Germany 3 329 1.3× 272 1.3× 53 0.7× 59 1.1× 10 0.2× 3 436
Francesca Bergomas Italy 6 337 1.3× 333 1.6× 76 1.1× 49 0.9× 7 0.1× 7 469
Fumiaki Shiratori Japan 10 98 0.4× 56 0.3× 79 1.1× 56 1.0× 40 0.8× 35 223
Minae An South Korea 6 189 0.8× 79 0.4× 110 1.5× 95 1.7× 9 0.2× 10 309
Jenny Lazarus United States 7 254 1.0× 162 0.8× 121 1.7× 46 0.8× 20 0.4× 11 348
Margareta Heby Sweden 10 168 0.7× 75 0.4× 82 1.1× 27 0.5× 9 0.2× 19 244
Miao Huang China 9 184 0.7× 50 0.2× 61 0.8× 159 2.9× 33 0.6× 17 298
Maria-Gabriela Aniței Romania 4 279 1.1× 135 0.6× 31 0.4× 39 0.7× 21 0.4× 9 340

Countries citing papers authored by Lea Lowenfeld

Since Specialization
Citations

This map shows the geographic impact of Lea Lowenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea Lowenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea Lowenfeld more than expected).

Fields of papers citing papers by Lea Lowenfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea Lowenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea Lowenfeld. The network helps show where Lea Lowenfeld may publish in the future.

Co-authorship network of co-authors of Lea Lowenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Lea Lowenfeld. A scholar is included among the top collaborators of Lea Lowenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea Lowenfeld. Lea Lowenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jafari, Mehraneh D., Heather Yeo, Lea Lowenfeld, et al.. (2024). 8MO Neoadjuvant botensilimab (BOT) plus balstilimab (BAL) in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial. Annals of Oncology. 35. S5–S6. 4 indexed citations
2.
Kasi, Pashtoon Murtaza, Mehraneh D. Jafari, Heather Yeo, et al.. (2024). Neoadjuvant botensilimab plus balstilimab in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial.. Journal of Clinical Oncology. 42(3_suppl). 117–117. 10 indexed citations
3.
4.
Lowenfeld, Lea & Fabrizio Michelassi. (2021). Managing Stricturing Crohn's Disease: Resect? Strictureplasty? Dilate?. Journal of Laparoendoscopic & Advanced Surgical Techniques. 31(8). 881–889.
5.
Urakawa, Shinya, et al.. (2021). Use of an endoscopic flexible grasper as a traction tool for excision of polyps: preclinical trial. Scientific Reports. 11(1). 18674–18674. 3 indexed citations
6.
Urakawa, Shinya, et al.. (2021). Use of endoscopic sleeve to achieve full-thickness endoscopic resection of malignant polyp under direct vision. Endoscopy. 54(7). E350–E352. 1 indexed citations
7.
Urakawa, Shinya, Teijiro Hirashita, Lea Lowenfeld, et al.. (2021). Novel percutaneous access to the large intestine using a double-balloon endoluminal platform for excision of a large polyp. Endoscopy. 54(7). E331–E333. 2 indexed citations
8.
Urakawa, Shinya, et al.. (2021). Novel Percutaneous Access to Large Intestine Using a Double Balloon Endolumenal Platform for Tumor Excision: Preclinical Trials and a Case Report. Journal of the American College of Surgeons. 233(5). e31–e32. 2 indexed citations
9.
Urakawa, Shinya, Kota Momose, Teijiro Hirashita, Lea Lowenfeld, & Jeffrey W. Milsom. (2020). Endoscopic submucosal dissection of large polyps in the right colon using an endoscopic snare with a double-balloon endolumenal interventional platform: an ex vivo study in a porcine colorectal model. Surgical Endoscopy. 35(11). 6319–6328. 8 indexed citations
10.
Lowenfeld, Lea & Kyle G. Cologne. (2019). Postoperative Considerations in Inflammatory Bowel Disease. Surgical Clinics of North America. 99(6). 1095–1109.
11.
12.
Lowenfeld, Lea, Rosemarie Mick, Jashodeep Datta, et al.. (2016). Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial. Clinical Cancer Research. 23(12). 2961–2971. 117 indexed citations
13.
Fracol, Megan, Jashodeep Datta, Lea Lowenfeld, et al.. (2016). Loss of Anti-HER-3 CD4+ T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes. Annals of Surgical Oncology. 24(2). 407–417. 15 indexed citations
14.
Datta, Jashodeep, Matthew T. McMillan, Luis I. Ruffolo, et al.. (2016). Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States. Annals of Surgical Oncology. 23(9). 2936–2945. 20 indexed citations
15.
16.
Datta, Jashodeep, Erik Berk, Shuwen Xu, et al.. (2015). Anti-HER2 CD4+ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer. Breast Cancer Research. 17(1). 71–71. 55 indexed citations
17.
Lowenfeld, Lea, Jashodeep Datta, Russell S. Lewis, et al.. (2015). Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival. Annals of Surgical Oncology. 22(S3). 863–872. 15 indexed citations
18.
Lowenfeld, Lea, Shuwen Xu, & Brian J. Czerniecki. (2015). CD4+ Th1 to the rescue in HER-2+ breast cancer. OncoImmunology. 8(10). e1078062–e1078062. 6 indexed citations
19.
Datta, Jashodeep, Lea Lowenfeld, Jessica A. Cintolo, et al.. (2014). Optimizing dendritic cell-based approaches for cancer immunotherapy.. PubMed. 87(4). 491–518. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matilde Monti Breakdown of academic impact, for papers by Thomas Broughton Breakdown of academic impact, for papers by Claudia Röefzaad Breakdown of academic impact, for papers by Francesca Bergomas Breakdown of academic impact, for papers by Fumiaki Shiratori Breakdown of academic impact, for papers by Minae An Breakdown of academic impact, for papers by Jenny Lazarus Breakdown of academic impact, for papers by Margareta Heby Breakdown of academic impact, for papers by Miao Huang Breakdown of academic impact, for papers by Maria-Gabriela Aniței
Rankless by CCL
2026